Knee pain injection study pulled before it even started
NCT ID NCT07024654
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test an injection of doxycycline into the knee area to reduce chronic pain in people with osteoarthritis who cannot have surgery. The trial was withdrawn before enrolling any participants, so no data was collected. The goal was to see if the procedure could safely ease pain and improve function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
doxycycline injection
What this could lead to
If it had worked, this could have pointed toward a new pain-relief option for people with knee osteoarthritis who cannot have surgery.
What could go wrong
The trial was withdrawn before enrolling anyone, so no results are available. It was a small early-stage study, and the procedure carries risks like infection or allergic reaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.